Xu Y - Search Results

1

The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2.

Li Z, Xu L, Tang N, Xu Y, Ye X, Shen S, Niu X, Lu S, Chen Z. Li Z, et al. Among authors: xu l, xu y. FEBS Lett. 2014 Aug 25;588(17):3000-7. doi: 10.1016/j.febslet.2014.05.057. Epub 2014 Jun 10. FEBS Lett. 2014. PMID: 24928441 Free article.

2

[Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Chen ZW, Ye XY, Lu S. Xu YH, et al. Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):716-9. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173920 Clinical Trial. Chinese.

3

[Short-term intermittent prophylactic administration of recombinant human thrombopoietin attenuates chemotherapy-induced thrombocytopenia in lung cancer patients].

Xu YH, Cheng BJ, Lu S, Jian H, Zhou Z, Chen ZW, Ye XY. Xu YH, et al. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):395-9. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875475 Clinical Trial. Chinese.

4

No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.

Xu YH, Gu LP, Sun YJ, Cheng BJ, Lu S. Xu YH, et al. Tumour Biol. 2013 Apr;34(2):865-74. doi: 10.1007/s13277-012-0619-5. Epub 2013 Jan 9. Tumour Biol. 2013. PMID: 23300009

5

Metformin inhibits esophagus cancer proliferation through upregulation of USP7.

Xu Y, Lu S. Xu Y, et al. Cell Physiol Biochem. 2013;32(5):1178-86. doi: 10.1159/000354517. Epub 2013 Nov 14. Cell Physiol Biochem. 2013. PMID: 24335168 Free article.

6

FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response.

Chen ZW, Liu B, Tang NW, Xu YH, Ye XY, Li ZM, Niu XM, Shen SP, Lu S, Xu L. Chen ZW, et al. Nucleic Acids Res. 2014 Oct;42(18):11560-9. doi: 10.1093/nar/gku876. Epub 2014 Sep 23. Nucleic Acids Res. 2014. PMID: 25249620 Free PMC article.

7

Transforming growth factor-β1-induced epithelial to mesenchymal transition increases mitochondrial content in the A549 non-small cell lung cancer cell line.

Xu Y, Lu S. Xu Y, et al. Mol Med Rep. 2015 Jan;11(1):417-21. doi: 10.3892/mmr.2014.2678. Epub 2014 Oct 16. Mol Med Rep. 2015. PMID: 25323156

8

17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.

Ye XY, Luo QQ, Xu YH, Tang NW, Niu XM, Li ZM, Shen SP, Lu S, Chen ZW. Ye XY, et al. J Cell Mol Med. 2015 Mar;19(3):651-63. doi: 10.1111/jcmm.12469. J Cell Mol Med. 2015. PMID: 25712415 Free PMC article.

9

Role of WNT1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A549 cells.

Xu Y, Lu S. Xu Y, et al. Int J Clin Exp Med. 2015 Sep 15;8(9):14962-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26628978 Free PMC article.

10

Clinical analysis of 95 cases of pulmonary sarcomatoid carcinoma.

Gu L, Xu Y, Chen Z, Pan Y, Lu S. Gu L, et al. Among authors: xu y. Biomed Pharmacother. 2015 Dec;76:134-40. doi: 10.1016/j.biopha.2015.10.009. Epub 2015 Nov 18. Biomed Pharmacother. 2015. PMID: 26653560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,669 results

Search Page

Filters